Analyzing Mercurity Fintech (NASDAQ:MFH) & GoodRx (NASDAQ:GDRX)
Mercurity Fintech (NASDAQ:MFH – Get Free Report) and GoodRx (NASDAQ:GDRX – Get Free Report) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends.
Analyst Ratings
This is a summary of current ratings and recommmendations for Mercurity Fintech and GoodRx, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Mercurity Fintech | 0 | 0 | 0 | 0 | N/A |
| GoodRx | 1 | 8 | 10 | 0 | 2.47 |
GoodRx has a consensus target price of $8.78, suggesting a potential upside of 34.63%. Given GoodRx’s higher probable upside, analysts plainly believe GoodRx is more favorable than Mercurity Fintech.
Profitability
This table compares Mercurity Fintech and GoodRx’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Mercurity Fintech | N/A | N/A | N/A |
| GoodRx | -1.18% | 2.45% | 1.25% |
Risk and Volatility
Mercurity Fintech has a beta of 2.02, suggesting that its stock price is 102% more volatile than the S&P 500. Comparatively, GoodRx has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500.
Institutional and Insider Ownership
30.8% of Mercurity Fintech shares are held by institutional investors. Comparatively, 63.8% of GoodRx shares are held by institutional investors. 62.8% of Mercurity Fintech shares are held by insiders. Comparatively, 1.4% of GoodRx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Valuation & Earnings
This table compares Mercurity Fintech and GoodRx’s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Mercurity Fintech | $326,591.00 | 179.58 | -$5.64 million | N/A | N/A |
| GoodRx | $750.27 million | 3.43 | -$8.87 million | ($0.02) | -325.84 |
Mercurity Fintech has higher earnings, but lower revenue than GoodRx.
Summary
GoodRx beats Mercurity Fintech on 6 of the 11 factors compared between the two stocks.
About Mercurity Fintech
Mercurity Fintech Holding Inc. operates as a fintech company powered by blockchain. The company provides digital asset trading infrastructure solutions based on internet and blockchain technologies for cryptocurrency traders; and asset digitalization platform, which offers blockchain-based digitalization solutions for traditional assets, such as fiat currencies, bonds, and precious metals. It also offers cryptocurrency mining services that provides computing power to the mining pool; and digital consultation services, such as digital payment solutions, asset management, and online and traditional brokerage services. The company was formerly known as JMU Limited and changed its name to Mercurity Fintech Holding Inc. in April 2020. Mercurity Fintech Holding Inc. was incorporated in 2011 and is headquartered in New York, New York.
About GoodRx
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
Receive News & Ratings for Mercurity Fintech Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Mercurity Fintech and related companies with MarketBeat.com’s FREE daily email newsletter.
